Clinical Trial Update: Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunochemotherapy with Zevalin (ibritumomab tiuxetan) and bone marrow transplant for follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: St. Louis University | Conditions: Follicular Lymphoma | Phase 2 | Status: COMPLETED